ciprofloxacin has been researched along with forapin in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (50.00) | 24.3611 |
2020's | 6 (50.00) | 2.80 |
Authors | Studies |
---|---|
Franzyk, H; Frimodt-Møller, N; Jahnsen, RD; Nielsen, HM; Sandberg-Schaal, A; Vissing, KJ | 1 |
Dong, N; Dou, X; Shan, A; Wang, J; Zhu, X | 1 |
Bartůněk, P; Benada, O; Bogdanová, K; Ehn, M; Fišer, R; Kolář, M; Krásný, L; Křížek, T; Panova, N; Pohl, R; Pospíšil, J; Rejman, D; Šanderová, H; Sedlák, D; Seydlová, G; Šimák, O; Sudzinová, P; Večeřová, R; Vítovská, D; Zborníková, E | 1 |
Chou, S; Dou, X; Shan, A; Song, J; Wang, J; Wang, Z; Yang, Y; Yang, Z | 1 |
Chen, T; Li, Z; Lyu, Y; Shan, A; Shang, L; Yang, Y; Zhu, J | 1 |
Kumar, SD; Rajasekaran, G; Shin, SY; Yang, S | 1 |
Liu, H; Long, S; Rakesh, KP; Zha, GF | 1 |
Bang, JK; Chirumarry, S; Gunasekaran, P; Han, J; Kim, EY; Lee, YH; Ryu, EK; Shin, SY; Soung, NK | 1 |
Cheng, B; Jian, Q; Lai, Z; Li, G; Shan, A; Shao, C; Tan, P; Zhu, Y | 1 |
Gou, S; Ni, J; Xie, J; Yao, J; Zhang, F; Zhong, C; Zhu, N; Zhu, Y | 1 |
Ba, Z; Chang, L; Gou, S; Li, B; Liu, H; Ni, J; Ouyang, X; Zhang, J; Zhang, T; Zhang, Y; Zhong, C; Zhu, N; Zhu, Y | 1 |
Akhtar, S; Ansari, MM; Ghosh, JK; Mitra, K; Pant, G; Pratap Verma, D; Saroj, J; Singh, BN; Verma, NK | 1 |
1 review(s) available for ciprofloxacin and forapin
Article | Year |
---|---|
Structure-activity relationships (SAR) of triazine derivatives: Promising antimicrobial agents.
Topics: Anti-Bacterial Agents; Antiviral Agents; Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Triazines; Viruses | 2020 |
11 other study(ies) available for ciprofloxacin and forapin
Article | Year |
---|---|
Tailoring cytotoxicity of antimicrobial peptidomimetics with high activity against multidrug-resistant Escherichia coli.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Antineoplastic Agents; Cell Proliferation; Circular Dichroism; Drug Resistance, Multiple; Gram-Negative Bacteria; Humans; Liposomes; Microbial Sensitivity Tests; Molecular Structure; Neoplasms; Peptidomimetics; Structure-Activity Relationship; Tumor Cells, Cultured | 2014 |
Novel Design of Heptad Amphiphiles To Enhance Cell Selectivity, Salt Resistance, Antibiofilm Properties and Their Membrane-Disruptive Mechanism.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Biofilms; Circular Dichroism; Drug Design; Hemolysis; Humans; Models, Molecular; Peptides; Protein Structure, Secondary; Pseudomonas aeruginosa; Pseudomonas Infections; Surface-Active Agents | 2017 |
Lipophosphonoxins II: Design, Synthesis, and Properties of Novel Broad Spectrum Antibacterial Agents.
Topics: Animals; Anti-Bacterial Agents; Apoptosis; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Survival; Drug Design; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Lipid Bilayers; Male; Mice, Inbred ICR; Microbial Sensitivity Tests; Phospholipids; Pyrazoles; Rabbits; Skin Irritancy Tests; Stereoisomerism; Structure-Activity Relationship; Uridine Monophosphate | 2017 |
Combating Drug-Resistant Fungi with Novel Imperfectly Amphipathic Palindromic Peptides.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; Candida albicans; Cytoplasm; Drug Resistance, Fungal; HEK293 Cells; Hemolysis; Humans; Hydrophobic and Hydrophilic Interactions; Intracellular Membranes; Inverted Repeat Sequences; Mice; Models, Molecular; Peptides; Protein Conformation; RAW 264.7 Cells | 2018 |
Design of Trp-Rich Dodecapeptides with Broad-Spectrum Antimicrobial Potency and Membrane-Disruptive Mechanism.
Topics: Anti-Infective Agents; Antimicrobial Cationic Peptides; Bacterial Outer Membrane; Drug Design; Escherichia coli; Humans; Microbial Sensitivity Tests; Oligopeptides; Peptide Fragments; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staphylococcus aureus; Tryptophan | 2019 |
The design of a cell-selective fowlicidin-1-derived peptide with both antimicrobial and anti-inflammatory activities.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cathelicidins; Cell Survival; Chickens; Dose-Response Relationship, Drug; Drug Design; Erythrocytes; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Molecular Structure; Peptide Fragments; RAW 264.7 Cells; Sheep; Structure-Activity Relationship | 2019 |
Antibacterial AZT derivative regulates metastasis of breast cancer cells.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Breast Neoplasms; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tumor Cells, Cultured; Wound Healing; Zidovudine | 2020 |
Rational Avoidance of Protease Cleavage Sites and Symmetrical End-Tagging Significantly Enhances the Stability and Therapeutic Potential of Antimicrobial Peptides.
Topics: Amino Acid Sequence; Animals; Anti-Inflammatory Agents; Antimicrobial Cationic Peptides; Binding Sites; Mice; Models, Molecular; Peptide Hydrolases; Protein Conformation; Protein Stability; RAW 264.7 Cells | 2020 |
Ultra-short lipopeptides against gram-positive bacteria while alleviating antimicrobial resistance.
Topics: Animals; Anti-Bacterial Agents; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Female; Gram-Positive Bacteria; Lipopeptides; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2021 |
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Pneumonia, Bacterial; Pore Forming Cytotoxic Proteins; Structure-Activity Relationship; Wasp Venoms | 2021 |
Tandem Repeat of a Short Human Chemerin-Derived Peptide and Its Nontoxic d-Lysine-Containing Enantiomer Display Broad-Spectrum Antimicrobial and Antitubercular Activities.
Topics: Animals; Antimicrobial Peptides; Antitubercular Agents; Cell Survival; Chemokines; Dose-Response Relationship, Drug; Erythrocytes; Humans; Lysine; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Pseudomonas aeruginosa; Pseudomonas Infections; Stereoisomerism; Structure-Activity Relationship; THP-1 Cells | 2021 |